Description: Polarean Imaging Plc operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The company manufactures, sells, and services hyperpolarizers and ancillary equipment for biomedical imaging research. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging Plc was founded in 2011 and is based in London, the United Kingdom.
Home Page: polarean.com
27-28 Eastcastle Street
London,
W1W 8DH
United Kingdom
Phone:
919 206 7900
Officers
Name | Title |
---|---|
Dr. Kenneth Paul West Ph.D. | Chairman of the Board |
Dr. Christopher Richard Von Jako Ph.D. | CEO & Director |
Dr. Bastiaan Driehuys Ph.D. | Founder, Chief Scientific Officer & Director |
Mr. Charles Fremont Osborne Jr. | CFO & Director |
Mr. Neil Wadehra | Vice President of Operations |
Mr. Alex Dusek | Chief Commercial Officer |
Dr. Chase Hall M.D. | Chief Medical Advisor |
Mr. Stephen Austin | Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.1447 |
Price-to-Sales TTM: | 11.1177 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 29 |